Gut microbiome signatures of Yorkshire Terrier enteropathy during disease and remission.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
16 03 2023
Historique:
received: 31 10 2022
accepted: 06 03 2023
entrez: 17 3 2023
pubmed: 18 3 2023
medline: 21 3 2023
Statut: epublish

Résumé

The role of the gut microbiome in developing Inflammatory Bowel Disease (IBD) in humans and dogs has received attention in recent years. Evidence suggests that IBD is associated with alterations in gut microbial composition, but further research is needed in veterinary medicine. The impact of IBD treatment on the gut microbiome needs to be better understood, especially in a breed-specific form of IBD in Yorkshire Terriers known as Yorkshire Terrier Enteropathy (YTE). This study aimed to investigate the difference in gut microbiome composition between YTE dogs during disease and remission and healthy Yorkshire Terriers. Our results showed a significant increase in specific taxa such as Clostridium sensu stricto 1, Escherichia-Shigella, and Streptococcus, and a decrease in Bacteroides, Prevotella, Alloprevotella, and Phascolarctobacterium in YTE dogs compared to healthy controls. No significant difference was found between the microbiome of dogs in remission and those with active disease, suggesting that the gut microbiome is affected beyond clinical recovery.

Identifiants

pubmed: 36927871
doi: 10.1038/s41598-023-31024-w
pii: 10.1038/s41598-023-31024-w
pmc: PMC10018597
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4337

Subventions

Organisme : Marie Curie
ID : 898858
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

J Vet Intern Med. 2014 Mar-Apr;28(2):331-7
pubmed: 24467282
J Vet Intern Med. 2019 Mar;33(2):383-402
pubmed: 30762910
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Curr Opin Gastroenterol. 2014 May;30(3):332-8
pubmed: 24625896
J Am Vet Med Assoc. 2000 Sep 1;217(5):703-6
pubmed: 10976303
World J Gastroenterol. 2010 Mar 7;16(9):1050-6
pubmed: 20205273
Open Vet J. 2021 Jan;10(4):412-430
pubmed: 33614437
J Small Anim Pract. 2016 Nov;57(11):589-599
pubmed: 27747868
Nat Rev Gastroenterol Hepatol. 2017 Oct;14(10):573-584
pubmed: 28743984
Vet Rec. 2017 Oct 7;181(14):370
pubmed: 28916525
World J Gastroenterol. 2014 Nov 28;20(44):16489-97
pubmed: 25469017
Inflamm Bowel Dis. 2018 May 18;24(6):1133-1148
pubmed: 29701818
PLoS One. 2022 Feb 24;17(2):e0264443
pubmed: 35202411
Front Med (Lausanne). 2018 Mar 21;5:75
pubmed: 29619371
Environ Microbiol. 2016 May;18(5):1403-14
pubmed: 26271760
J Vet Intern Med. 2019 Jul;33(4):1608-1618
pubmed: 31099928
Sci Rep. 2022 Jul 28;12(1):12977
pubmed: 35902689
Front Nutr. 2021 May 13;8:638825
pubmed: 34055851
F1000Res. 2016 Jun 24;5:1492
pubmed: 27508062
PLoS One. 2014 Sep 17;9(9):e107909
pubmed: 25229475
J Vet Intern Med. 2007 Jul-Aug;21(4):700-8
pubmed: 17708389
Cell Mol Gastroenterol Hepatol. 2015 Mar 1;1(2):154-170
pubmed: 26000334
NPJ Biofilms Microbiomes. 2019 Jan 21;5(1):4
pubmed: 30675371
Scand J Gastroenterol. 2010 Oct;45(10):1141-9
pubmed: 20497046
Vet Clin North Am Small Anim Pract. 2021 May;51(3):605-621
pubmed: 33653538
J Comp Pathol. 2008 Feb-Apr;138 Suppl 1:S1-43
pubmed: 18336828
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4554-61
pubmed: 20847294
J Vet Intern Med. 2020 May;34(3):1177-1186
pubmed: 32282988
Metabolites. 2022 Mar 19;12(3):
pubmed: 35323707
J Vet Intern Med. 2020 Sep;34(5):1853-1866
pubmed: 32856349
J Vet Intern Med. 2008 May-Jun;22(3):553-60
pubmed: 18466244
Front Microbiol. 2021 Jun 22;12:685935
pubmed: 34239510
Gastroenterology. 2021 Jan;160(2):524-537
pubmed: 33253681
Nat Microbiol. 2016 Oct 03;1:16177
pubmed: 27694806
Front Microbiol. 2021 May 20;12:669776
pubmed: 34093488
Dis Markers. 2022 Feb 8;2022:2941248
pubmed: 35178126
Comput Struct Biotechnol J. 2021 May 04;19:2687-2698
pubmed: 34093985
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):228-33
pubmed: 19966295
PLoS One. 2013;8(1):e53115
pubmed: 23382835
PLoS One. 2019 Oct 31;14(10):e0224454
pubmed: 31671166
J Vet Intern Med. 2010 Jan-Feb;24(1):10-26
pubmed: 20391635
Front Genet. 2021 Jun 21;12:649599
pubmed: 34239536
Front Toxicol. 2021 Nov 10;3:773953
pubmed: 35295115
FEMS Microbiol Ecol. 2011 Dec;78(3):542-54
pubmed: 22067056
World J Gastroenterol. 2015 Nov 21;21(43):12296-310
pubmed: 26604638
Brief Bioinform. 2021 Jan 18;22(1):178-193
pubmed: 31848574
Cells. 2020 Mar 28;9(4):
pubmed: 32231153

Auteurs

Pavlos G Doulidis (PG)

Department for Small Animal Internal Medicine, Clinic for Small Animals and Horses, University of Veterinary Medicine, Vienna, Austria.

Alexandra I Galler (AI)

Department for Small Animal Internal Medicine, Clinic for Small Animals and Horses, University of Veterinary Medicine, Vienna, Austria.

Bela Hausmann (B)

Joint Microbiome Facility of the Medical University of Vienna, University of Vienna, Vienna, Austria.
Division of Microbiology, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

David Berry (D)

Joint Microbiome Facility of the Medical University of Vienna, University of Vienna, Vienna, Austria.
Centre for Microbiology and Environmental Systems Science, Department of Microbiology and Ecosystem Science, Division of Microbial Ecology, University of Vienna, Vienna, Austria.

Alexandro Rodríguez-Rojas (A)

Department for Small Animal Internal Medicine, Clinic for Small Animals and Horses, University of Veterinary Medicine, Vienna, Austria.

Iwan A Burgener (IA)

Department for Small Animal Internal Medicine, Clinic for Small Animals and Horses, University of Veterinary Medicine, Vienna, Austria. Iwan.Burgener@vetmeduni.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH